Bunge Limited (BG)


Bunge Limited (NYSE: BG) is a common stock listing tied to Bunge Global SA, a global agribusiness and food company. Its operations span soybean, softseed, and other oilseed processing and refining, along with grain merchandising and milling. The company’s activities include sourcing, storing, moving, processing, refining, and selling agricultural commodities and related products, as well as selected activities linked to biodiesel, fertilizer, milling, ocean freight, and financial services. Its grain-related business focuses on commodities such as corn, wheat, barley, cotton, pulses, and sugar. Bunge was founded in 1818 and is headquartered in Chesterfield, Missouri.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-BG
$95.28
-21.3% Downside
Overvalued
$141.44
16.8% Upside
Fair
Fair
February 16, 2027
March 2, 2027
2.88
2.4%
July 29, 2026
34.1x
1.5x
0.3x
23.377 B
38.109 B
39.8%
82.3%
3.1
73.8%
-169.2%
Valuation • Fair Value

Bunge Limited (NYSE-BG) Fair Value by Valuation Model

Compare the primary fair value estimate for Bunge Limited (NYSE-BG) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$95.28

Estimated downside of 21.3% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$86.47

Discounted cash flow valuation reference.

Ben Graham Formula Value

$39.23

Classic Ben Graham valuation formula reference.

DDM Fair Value

$124.05

Dividend discount model valuation reference.

EPV Fair Value

$60.30

Earnings power value estimate.

Comps Fair Value

$100.33

Comparable-company valuation reference.

Analyst Price Target

$141.44

Analysts imply upside of 16.8%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Bunge Limited (NYSE-BG) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Bunge Limited (NYSE-BG)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

80.547 B

Current operating scale indicator.

Revenue Forecast

90.762 B

Forward revenue estimate.

EBITDA

2.234 B

Current operating profitability reference.

EBITDA Forecast

3.945 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Bunge Limited (NYSE-BG) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Bunge Limited (NYSE-BG)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

-1.56

Higher caution zone on this screen.

Altman Z-Score

3.1

Relatively strong balance-sheet zone.

FCF / Net Income

-169.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Bunge Limited (NYSE-BG). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Bunge Limited (NYSE-BG)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 29, 2026

Days to Earnings

8

Dividend Payment Date

March 2, 2027

Ex-Dividend Date

February 16, 2027

Dividend Yield

2.4%

Income yield reference.

Upcoming Dividend

2.88

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

73.8%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Bunge Limited (NYSE-BG), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Bunge Limited (NYSE-BG) Stock Forecast & Technical Outlook

Review Bunge Limited (NYSE-BG) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Bunge Limited (NYSE-BG) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Bunge Limited (NYSE-BG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Bunge Limited (NYSE-BG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Bunge Limited (NYSE-BG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Bunge Limited (NYSE-BG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Bunge Limited (NYSE-BG)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Bunge Limited (NYSE-BG) has a Strong Buy consensus, with 5 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 5
Hold 1
Sell 0
FAQ Fast Investor Answers

Bunge Limited (NYSE-BG) Stock FAQ

Quick answers about Bunge Limited (NYSE-BG) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$95.28
Estimated downside 21.3%
Valuation Rating
Overvalued
Estimated downside of 21.3%
Analyst Target
$141.44
Implied upside 16.8%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Bunge Limited (NYSE-BG) is $95.28. This implies an estimated downside of 21.3% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 21.3% versus the current market price.

The available analyst price target for Bunge Limited (NYSE-BG) is $141.44. The analyst target implies estimated upside of 16.8%.

The current financial health read for Bunge Limited (NYSE-BG) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Bunge Limited (NYSE-BG) is July 29, 2026.

Based on the current data, dividend yield is 2.4%, upcoming dividend amount is 2.88, ex-dividend date is February 16, 2027, payment date is March 2, 2027.

The current P/E ratio listed for Bunge Limited (NYSE-BG) is 34.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Bunge Limited is 23.377 B.

The current enterprise value listed for Bunge Limited is 38.109 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Bunge Limited is NYSE-BG, and the stock is listed on NYSE.

Bunge Limited (NYSE-BG) is listed on NYSE.

The current debt-to-total-capital ratio listed for Bunge Limited is 39.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Bunge Limited is 82.3%. Free float helps investors understand how much of the share base is available for public trading.